Delivery Order SPE2DB22D1017-SPE2DB24FG2VW
Award Date
8/8/24
Potential Completion Date
8/9/24
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government has awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply Glimepiride 4 mg tablets. The contract, valued at $1,343.40, is funded by the Defense Logistics Agency (DLA), a defense agency. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which enables the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GLIMEPIRIDE 1 MG TABLET 100S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,138.32 and an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,153.02 Firm Fixed Price delivery order contract covers the supply of 4567721896 - GLIMEPIRIDE 4 MG TABLET 100S, with a performance period through March 28, 2025. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,575.07 firm fixed-price delivery order is for 4,567,102,251 units of the drug Glimepiride 4 mg tablets. The contract has an ultimate completion date of January 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide Glimepiride 4 mg tablet 100s to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $2,849.69 and an Ultimate Completion Date of September 19, 2024. Amerisourcebergen has a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,316.49 Firm Fixed Price Delivery Order covers the supply of 4,567,751,489 units of the generic drug Glimepiride 2 mg tablets. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,326.08, is for the delivery of 4,568,142,317 units of the diabetes medication Glimepiride 2 mg tablets. The contract has a period of performance through May 6, 2025 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GLIMEPIRIDE 4 MG TABLET 100S. The contract has a total potential value of $12,852.36 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp, a for-profit organization, will perform the work from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is part of a...
This is a $3,916.47 delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 tablets of the drug Glimepiride 2 mg, which is used to treat diabetes. The contract is a firm fixed-price, non-set-aside contract with a completion date of May 29, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,826.50 firm fixed-price delivery order contract is for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a medication used for the treatment of diabetes. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...